1例胱氨酸尿症家系的临床表型和基因型分析

内科理论与实践››2023,Vol. 18››Issue (03): 146-151.doi:10.16138/j.1673-6087.2023.03.003

1例胱氨酸尿症家系的临床表型和基因型分析

王子秋^1a^,², 倪莉燕^1a, 乔盼盼^1c, 谭陶然^1a^,³, 谢静远^1a, 陈晓农^1a, 唐永华^1b(), 王朝晖^1a()

1.开云网页登录医学院附属瑞金医院a. 肾脏内科；b. 放射科；c. 肾脏内科（北部），上海 200025
2.开云网页登录医学院附属瑞金医院卢湾分院肾脏科，上海 200020
3.昆明市延安医院呈贡医院肾脏内科，云南昆明 650504

收稿日期:2022-01-05出版日期:2023-06-30发布日期:2023-08-07
通讯作者:王朝晖 E-mail: wzhaohui2001@163.com ；唐永华 E-mail: tyh10636@rjh.com.cn

Clinical features, diagnosis and genetic analysis of a family with cystinuria

WANG Ziqiu^1a^,², NI Liyan^1a, QIAO Panpan^1c, TAN Taoran^1a^,³, XIE Jingyuan^1a, CHEN Xiaonong^1a, TANG Yonghua^1b(), WANG Zhaohui^1a()

1. a. Department of Nephrology; b. Department of Radiology; c. North Branch Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
2. Department of Nephrology, Luwan Branch, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200020, China
3. Department of Nephrology, Kunming Yan’an Chenggong Hospital, Kunmin 650504, China

Received:2022-01-05Online:2023-06-30Published:2023-08-07

摘要/Abstract

摘要：

目的:通过分析1例胱氨酸尿症家系，探讨胱氨酸尿症的临床特征、诊治要点及遗传因素。方法:回顾分析1例胱氨酸尿症家系病例资料，先证者为28岁男性。通过尿沉渣镜检、能谱CT测定先证者结石成分，提取先证者及家系成员外周血DNA样本，利用目标序列捕获高通量测序技术筛查突变基因。结果:该家系先证者首诊于15岁。主要临床表现为复发性左侧泌尿道结石合并蛋白尿，其母亲主要表现为蛋白尿，父亲无肾脏受累症状。测序结果示先证者存在溶质载体家族3成员1（solute carrier family 3, member 1，SLC3A1）基因复合杂合突变，其中包括移码突变NM_000341:exon3:c.703delG（母亲为该杂合突变携带者）及错义突变NM_000341:exon8:c.1366C>T（父亲为该杂合突变携带者）。两突变均判定为疑似致病性变异。先证者有多次输尿管镜取石术史，尿沉渣镜检中可找到特异性胱氨酸六边形晶体，能谱CT结石成分测定为L-胱氨酸。先证者确诊为胱氨酸尿症后，予碱化尿液、降蛋白尿等治疗，目前病情稳定。结论:尿沉渣镜检中找到六边形晶体是胱氨酸尿症的特异性诊断手段，胱氨酸能谱CT可无创诊断胱氨酸结石。对起病年龄小的复发性结石患者应高度怀疑遗传疾病，基因检测是胱氨酸尿症的病因诊断方式。

关键词:胱氨酸尿症,肾结石,复合杂合,基因测序,能谱CT

Abstract:

ObjectiveTo explore the clinical features, diagnosis and treatment points and genetic factors of cystinuria by analyzing a family with cystinuria.MethodsThe proband was a 28-year-old male, and the data of the family with cystinuria was retrospectively analyzed. The stone composition of the proband was determined by urine sediment microscopy, energy spectrum CT and infrared spectroscopy. The peripheral blood DNA samples of the proband and family members were extracted and captured by the target sequence. High-throughput sequencing technology was used to screen mutant genes, and the progress of diagnosis and treatment of cystinuria was discussed referring to literatures.ResultsThe proband in this family was firstly diagnosed at 15 years old. His main clinical manifestation was recurrent left urinary tract calculi combined with proteinuria. The mother’s main manifestation was proteinuria, and the father had no symptoms related to kidney. The sequencing results showed that the proband had a compound heterozygous mutation in the solute carrier family 3, member 1(SLC3A1) gene, including the frameshift mutation NM_000341:exon3:c.703delG ( mother was the carrier of the heterozygous mutation) and missense mutation NM_000341:exon8:c.1366C>T (father is a carrier of the heterozygous mutation). According to American College of Medical Genetics and Genomics(ACMG) guidelines, both mutations were classified as suspected pathogenic variants. The proband had a history of multiple ureteroscopic lithotripsy, and specific hexagonal crystals could be found in urine sedimentary mirror examination and the stone composition was determined to be L-cystine by spectrum CT. After being diagnoses as cystinuria, the proband was treated with alkalization of urine and proteinuria, and his current condition was stable.ConclusionsA specific diagnostic method for cystinuria is to find hexagonal crystals in urine sediment microscopy. Spectrum CT can be applied to diagnose cystine stones non-invasively. Genetic disease should be strongly considered in the patients with recurrent stones at young age, and genetic testing can be used as etiological diagnosis method for cystinuria.

Key words:Cystinuria,Nephrolithiasis,Compound heterozygosity,Gene sequencing

中图分类号:

王子秋, 倪莉燕, 乔盼盼, 谭陶然, 谢静远, 陈晓农, 唐永华, 王朝晖. 1例胱氨酸尿症家系的临床表型和基因型分析[J]. 内科理论与实践, 2023, 18(03): 146-151.

WANG Ziqiu, NI Liyan, QIAO Panpan, TAN Taoran, XIE Jingyuan, CHEN Xiaonong, TANG Yonghua, WANG Zhaohui. Clinical features, diagnosis and genetic analysis of a family with cystinuria[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(03): 146-151.

图/表6

参考文献16

[1]	Eisner BH, Goldfarb DS, Baum MA, et al. Evaluation and medical management of patients with cystine nephrolithiasis[J]. J Endourol, 2020, 34(11): 1103-1110. doi:10.1089/end.2019.0703 URL
[2]	Li C, Yang Y, Zheng Y, et al. Genetic and clinical analyses of 13 Chinese families with cystine urolithiasis and identification of 15 novel pathogenic variants inSLC3A1andSLC7A9[J]. Front Genet, 2020, 11: 74. doi:10.3389/fgene.2020.00074 URL
[3]	Rhodes HL, Yarram-Smith L, Rice SJ, et al. Clinical and genetic analysis of patients with cystinuria in the United Kingdom[J]. Clin J Am Soc Nephrol, 2015, 10(7): 1235-1245. doi:10.2215/CJN.10981114 URL
[4]	Servais A, Thomas K, Dello Strologo L, et al. Cystinuria: clinical practice recommendation[J]. Kidney Int, 2021, 99(1): 48-58. doi:10.1016/j.kint.2020.06.035pmid:32918941
[5]	Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424. doi:10.1038/gim.2015.30pmid:25741868
[6]	Sahota A, Tischfield JA, Goldfarb DS, et al. Cystinuria: genetic aspects, mouse models, and a new approach to therapy[J]. Urolithiasis, 2019, 47(1): 57-66. doi:10.1007/s00240-018-1101-7pmid:30515543
[7]	Font-Llitjós M, Jiménez-Vidal M, Bisceglia L, et al. New insights into cystinuria: 40 new mutations, genotype-phenotype correlation, and digenic inheritance causing partial phenotype[J]. J Med Genet, 2005, 42(1): 58-68. pmid:15635077
[8]	Alghamdi M, Alhasan KA, Taha Elawad A, et al. Diversity of phenotype and genetic etiology of 23 cystinuria saudi patients[J]. Front Pediatr, 2020, 8: 569389. doi:10.3389/fped.2020.569389 URL
[9]	Daga A, Majmundar AJ, Braun DA, et al. Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis[J]. Kidney Int, 2018, 93(1): 204-213. doi:10.1016/j.kint.2017.06.025 URL
[10]	Daga S, Palit V, Forster JA, et al. An update on evaluation and management in cystinuria[J]. Urology, 2021, 149: 70-75. doi:10.1016/j.urology.2020.12.025pmid:33421442
[11]	Rajiah P, Parakh A, Kay F, et al. Update on multienergy CT: physics, principles, and applications[J]. 2020, 40(5): 1284-1308.
[12]	张玉娇, 李小虎, 江兆翔, 等. 双能量能谱CT分析体内尿酸结石的诊断价值[J]. 安徽医科大学学报, 2017, 52(7): 1901-1904.
[13]	Rompsaithong U, Jongjitaree K, Korpraphong P, et al. Characterization of renal stone composition by using fast kilovoltage switching dual-energy computed tomography compared to laboratory stone analysis[J]. Abdom Radiol (NY), 2019, 44(3): 1027-1032. doi:10.1007/s00261-018-1787-6pmid:30259102
[14]	Shah TT, Gao C, Peters M, et al. Factors associated with spontaneous stone passage in a contemporary cohort of patients presenting with acute ureteric colic[J]. BJU Int, 2019, 124(3): 504-513. doi:10.1111/bju.14777 URL
[15]	Thomas K, Wong K, Withington J, et al. Cystinuria—a urologist’s perspective[J]. Nat Rev Urol, 2014, 11(5):270-277. doi:10.1038/nrurol.2014.51pmid:24662732
[16]	Chillarón J, Font-Llitjós M, Fort J, et al. Pathophysiology and treatment of cystinuria[J]. Nat Rev Nephrol, 2010, 6(7): 424-434. doi:10.1038/nrneph.2010.69pmid:20517292